Read + Share
Amedeo Smart
Independent Medical Education
Naccarelli GV, Kowey PR. Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy? J Cardiovasc Electrophysiol 2022 Nov 6. doi: 10.1111/jce.15732.PMID: 36335634
Email
LinkedIn
Facebook
Twitter
Privacy Policy